BID | 47.63 | ASK | 47.68 | ||
Open | 47.30 | Previous Close | 47.34 | ||
Pre-Market | - | After-Market | - | ||
- - | - -% |
Target Price | 56.57 | Analyst Rating | — — 0.00 | |
Potential % | 18.62 | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★+ 44.42 | |
Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | — - | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
Market Cap | 2.65B | Earnings Rating | — | |
Price Range Ratio 52W % | 51.98 | Earnings Date | 7th Jan 2021 |
Today's Price Range 46.1347.89 | 52W Range 28.6865.25 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | 1.08% | ||
1 Month | 0.95% | ||
3 Months | -8.90% | ||
6 Months | 14.56% | ||
1 Year | 60.03% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -561.41 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -105.99 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -456.70 | |||
Return on invested Capital Q | -5.71 | |||
Return on invested Capital Y | - | |||
Assets Turnover | 0.40 | |||
Receivables Turnover | 12.30 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-5.80 | ||||
7.06 | ||||
24.95 | ||||
- | ||||
-73.80 | ||||
-0.83 | ||||
7.15 | ||||
6.63 | ||||
2.32B | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
5.90 | ||||
6.10 | ||||
- | ||||
- | ||||
-9.60 | ||||
Leverage Ratio | 2.90 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
43.40 | ||||
-27.90 | ||||
-22.60 | ||||
- | ||||
-41.33 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
111.13M | ||||
1.90 | ||||
- | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2021 | -0.35 | -0.32 | 8.57 |
Q02 2021 | -0.42 | -0.47 | -11.90 |
Q01 2021 | - | -1.86 | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | - |
Estimated EPS Next Report | -0.35 |
Estimates Count | 7 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 312.35K |
Shares Outstanding | 55.49M |
Trades Count | 4.64K |
Dollar Volume | 51.43M |
Avg. Volume | 986.41K |
Avg. Weekly Volume | 446.19K |
Avg. Monthly Volume | 1.02M |
Avg. Quarterly Volume | 973.69K |
Accolade Inc. (NASDAQ: ACCD) stock closed at 47.69 per share at the end of the most recent trading day (a 0.74% change compared to the prior day closing price) with a volume of 313.30K shares and market capitalization of 2.65B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 1230 people. Accolade Inc. CEO is Rajeev Singh.
The one-year performance of Accolade Inc. stock is 60.03%, while year-to-date (YTD) performance is 9.63%. ACCD stock has a five-year performance of %. Its 52-week range is between 28.68 and 65.25, which gives ACCD stock a 52-week price range ratio of 51.98%
Accolade Inc. currently has a PE ratio of -5.80, a price-to-book (PB) ratio of 7.06, a price-to-sale (PS) ratio of 24.95, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -105.99%, a ROC of -456.70% and a ROE of -561.41%. The company’s profit margin is -41.33%, its EBITDA margin is -22.60%, and its revenue ttm is $111.13 Million , which makes it $1.90 revenue per share.
Of the last four earnings reports from Accolade Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.35 for the next earnings report. Accolade Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Accolade Inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Accolade Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Accolade Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Accolade Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.38, ATR14 : 3.36, CCI20 : 53.88, Chaikin Money Flow : -0.06, MACD : -1.11, Money Flow Index : 59.63, ROC : 7.24, RSI : 44.65, STOCH (14,3) : 75.03, STOCH RSI : 1.00, UO : 53.55, Williams %R : -24.97), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Accolade Inc. in the last 12-months were:
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | - | - | - |
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
CEO: Rajeev Singh
Telephone: +1 206 926-8100
Address: 1201 Third Avenue, Seattle 98101, WA, US
Number of employees: 1 230
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.